3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Lung Neoplasms
4
Clear-cell metastatic renal cell carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Radiotherapy
2
Radiation
2
Brachytherapy
2
trastuzumab deruxtecan
1
talazoparib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Doxorubicin
1
Dehydroepiandrosterone
1
Congresses as Topic
1
Cisplatin
1
Bupropion
1
Bevacizumab
1
Axitinib
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.